RankingsPricing
  1. US-listed companies
  2. GILEAD SCIENCES, INC.
  3. Financials
  4. Cash from investing

GILEAD SCIENCES, INC.GILD

Market cap
$157.7B
P/E ratio
SummaryFinancials
Period EndCash from investing (Million USD)YoY (%)
Dec 31, 2024-3,449+52.27%
Dec 31, 2023-2,265-8.15%
Dec 31, 2022-2,466-21.24%
Dec 31, 2021-3,131-78.58%
Dec 31, 2020-14,615+86.96%
Dec 31, 2019-7,817-154.45%
Dec 31, 201814,355-189.33%
Dec 31, 2017-16,069+34.08%
Dec 31, 2016-11,985-3.93%
Dec 31, 2015-12,475+584.31%
Dec 31, 2014-1,823+616.71%
Dec 31, 2013-254-97.85%
Dec 31, 2012-11,846-429.99%
Dec 31, 20113,590-285.26%
Dec 31, 2010-1,938

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)